
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ | Optometry Times - Clinical News
Published on December 3, 2025

This is the first submission for approval under the exclusive license and commercialization agreement for South Korea that was signed between LENZ and Lotus.
